IMBT technology utilises an insect’s natural genetic makeup to produce an array of  AMPs, and their associated immune function components when they are immune stimulated. These immune stimulated insects given as feed supplements reinforce an animal's Innate Immune system and its defences against pathogenic, bacterial, viral, fungal and parasitic infections, which may have been reduced either through genetic pre-disposition or the subversive activity that the pathogen has on the animal’s immune system.


The various AMPs within this array have different targets on a pathogen, this then produces a multitude of antigen complexes that are the basis for antibody production. The variety of the AMPs increases the diversity of antibody production repertoire in a vertebrate. Invertebrates do not have an adaptive immune system and do not produce antibodies

 IMBT technology also enhances the recipient’s ability to fight infection through decreasing the production of the anti-inflammatory cytokine IL-10. The production of this cytokine is associated with a decreased immune status. Pathogens often incorporate an IL-10 increased production strategy, to subvert an animal’s immune system.


IMBT was established in 1999 to research and commercialise the Concept of ‘Immunity Generation’: The induced production of Immune enhancing compounds in one species with their subsequent transfer (normally though ingestion) to another species, wherein they provide an immune-boosting capability.



  • A natural animal feed with added value AMP supplement. Antimicrobials harnessed from nature.

  • IP Protected (Granted in UK and Australia and new PCT has recently been filed following advancements with the technology. UK, EU, USA, Canada, Chile, China, Australia and Vietnam.)

  • Addresses current demands to tackle AMR (Antimicrobial resistance)

  • A unique natural non-GM technology that converts low-value plant waste to a high-value antimicrobial feed.

  • Promotes better growth rates and food conversion rates in animals

  • Uses the complete immune response of an insect. Recent published research has shown that using AMPS in isolation, leads, as with antibiotics, to antimicrobial resistance mechanisms evolving.

  • IMBT technology does not disrupt good gut bacteria and gut function

  • IMBT technology is sustainable and is based on a process that has lasted millions of years

  • IMBT technology is environmentally friendly; it does not produce components that pollute water courses or the environment

  • Enhances value throughout the whole food chain

  • Technology utilises existing carbon from the food chain, is part of the circular economy

  • Potential to promote plant health through enrichment of soil and transfer of immune components via plant root hairs.